A study on rheumatoid arthritis showed that high-dose silibinin significantly reduced inflammatory markers (ESR, IL-8, IL-6, TNF-α, anti-CCP) and increased Hb, IL-10, and IL-2, compared to placebo [34]. This evidence concerns the gene TNF and rheumatoid arthritis.